Bingjie Wang Selected Research

Bingjie Wang Research Topics

Disease

15	Neoplasms (Cancer) 09/2022 - 12/2015
11	Infections 01/2022 - 07/2015
6	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2018
6	Myopia 01/2021 - 01/2015
3	Multiple Myeloma 01/2022 - 01/2021
2	Immunoglobulin Light-chain Amyloidosis 01/2022 - 01/2021
2	Vascular Diseases (Vascular Disease) 01/2022 - 01/2020
2	Bacterial Infections (Bacterial Infection) 01/2022 - 11/2019
2	Communicable Diseases (Infectious Diseases) 01/2022 - 01/2021
2	Pain (Aches) 03/2021 - 01/2020
2	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 09/2017
2	Superinfection 04/2018 - 07/2015
1	Squamous Intraepithelial Lesions 09/2022
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2022
1	Colorectal Neoplasms (Colorectal Cancer) 08/2022
1	Carcinogenesis 08/2022
1	Papillomavirus Infections 03/2022
1	Uterine Cervical Dysplasia 03/2022
1	Lymphoma (Lymphomas) 01/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022
1	Colonic Neoplasms (Colon Cancer) 01/2022
1	Tularemia 01/2022
1	Aneuploidy (Aneuploid) 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Retinal Vein Occlusion 01/2022
1	Stress Urinary Incontinence 10/2021
1	Oral Lichen Planus 03/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 02/2021
1	Necrotizing Enterocolitis 01/2021
1	Pleural Effusion (Pleural Effusions) 01/2021
1	Disease Progression 01/2021
1	Schizophrenia (Dementia Praecox) 01/2021
1	Amyloidosis 01/2021

Drug/Important Bio-Agent (IBA)

7	1-phenyl-3,3-dimethyltriazene (PDT)IBA 09/2022 - 09/2018
6	Pharmaceutical PreparationsIBA 01/2022 - 01/2017
5	AcidsIBA 09/2022 - 12/2020
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2021
5	CytokinesIBA 01/2022 - 12/2019
5	CurcuminIBA 12/2019 - 01/2018
3	AntigensIBA 01/2022 - 11/2019
3	AntibodiesIBA 10/2020 - 07/2015
3	MicellesIBA 12/2019 - 01/2018
3	PolymersIBA 12/2019 - 01/2018
3	CollagenIBA 12/2017 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2019
2	baicalinIBA 01/2022 - 12/2019
2	Carbapenems (Carbapenem Antibiotics)IBA 01/2022 - 01/2021
2	PolyphenolsIBA 01/2022 - 01/2022
2	Polysaccharides (Glycans)IBA 01/2022 - 12/2020
2	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2021
2	Retinaldehyde (Retinal)IBA 01/2022 - 01/2020
2	Riboflavin (Vitamin B2)FDA LinkGeneric 01/2022 - 01/2016
2	Interleukin-23 (Interleukin 23)IBA 01/2022 - 11/2019
2	TeaIBA 01/2022 - 01/2022
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 10/2020
2	Estrogen ReceptorsIBA 12/2021 - 12/2020
2	Virulence Factors (Pathogenicity Factors)IBA 06/2021 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 10/2020
2	Folic Acid (Vitamin M)FDA LinkGeneric 12/2020 - 12/2019
2	Hyaluronic Acid (Hyaluronan)IBA 12/2019 - 01/2018
2	laminaranIBA 09/2019 - 09/2018
1	Oncogene Proteins (Oncogene Protein)IBA 09/2022
1	Messenger RNA (mRNA)IBA 09/2022
1	Circular RNAIBA 08/2022
1	Cadherins (E-Cadherin)IBA 08/2022
1	human MIRN619 microRNAIBA 08/2022
1	5-hydroxymethylcytosineIBA 01/2022
1	Biological ProductsIBA 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	Propidium (Propidium Iodide)IBA 01/2022
1	carbapenemaseIBA 01/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022
1	Interleukin-12 (IL 12)IBA 01/2022
1	Tumor Biomarkers (Tumor Markers)IBA 12/2021
1	ChromatinIBA 12/2021
1	Estradiol (Delestrogen)FDA LinkGeneric 12/2021
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 12/2021
1	Sirtuin 1IBA 10/2021
1	ElementsIBA 06/2021
1	QuinolonesIBA 06/2021
1	SteroidsIBA 03/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2021
1	GlucocorticoidsIBA 02/2021
1	FluoroquinolonesIBA 01/2021
1	Granzymes (Granzyme)IBA 01/2021
1	Interleukin-2 (IL2)IBA 01/2021
1	InterferonsIBA 01/2021
1	Interleukin-17 (Interleukin 17)IBA 01/2021
1	Daptomycin FDA Link 01/2021
1	TeicoplaninIBA 01/2021
1	Immunologic Factors (Immunomodulators)IBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2021

Therapy/Procedure

12	Therapeutics 08/2022 - 09/2014
7	Photochemotherapy (Photodynamic Therapy) 09/2022 - 03/2019
6	Drug Therapy (Chemotherapy) 01/2022 - 01/2017
2	Laser In Situ Keratomileusis (LASIK) 06/2016 - 01/2015
2	Lasers (Laser) 06/2016 - 12/2015
1	Hysterectomy 03/2022
1	Low-Level Light Therapy (LLLT) 03/2021